ADVERTISEMENT

India Pesticides IPO - Niche Company At Reasonable Valuations: Prabhudas Lilladher

India Pesticides IPO - Niche Company At Reasonable Valuations: Prabhudas Lilladher

Pesticide foams from the nozzle of crop spraying equipment held by a worker on the farm of Jarnail Singh in Jajjal village, Punjab. (Photographer: Prashanth Vishwanathan/Bloomberg).
Pesticide foams from the nozzle of crop spraying equipment held by a worker on the farm of Jarnail Singh in Jajjal village, Punjab. (Photographer: Prashanth Vishwanathan/Bloomberg).

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Prabhudas Lilladher Report

India Pesticides Ltd. is a niche play in manufacturing of pesticides technical (79% of revenue) and formulation (21%).

Our positive stance emanates from-

1. it is the sole manufacturer of five technical in India and leading manufacturer of certain molecules like Captan, Folpet and Thiocarbamate herbicide and

2. none of its technical molecules are classified under “red triangle”.

The company reported a topline/Ebitda/profit after tax compound annual growth rate of 38%/67%/75% over FY19-21.

We expect growth momentum to sustain led by

1. six to eight molecules to be commercialised at its new 10,000 million tonnes per annum capacity expansion and

2. greenfield expansion at a new site for which the company is currently in discussion with Uttar Pradesh government to acquire land.

Click on the attachment to read the full report:

Prabhudas Lilladher India Pesticides IPO Note.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.